Anna Wec, PhD

Associate Director, Infectious Disease Research, Immunology at Moderna

Speaker

Anna joined Moderna Therapeutics in 2023 and is currently an Associate Director in the Infectious Disease Research department. In this role, Anna has been leading antibody discovery to infectious disease targets and working on strategies to optimize antibody delivery using mRNA LNPs. Prior to joining Moderna, Anna led a small team in antibody discovery and preclinical development at Invivyd, contributing to the development of the currently authorized Pemgarda. From 2020-2022 at Dyno therapeutics, she led the effort to reduce recognition of AAV capsids by preexisting human antibodies, bridging the wet lab and Machine Learning. Prior to that, Anna worked as a discovery scientist at Adimab, characterizing immune B cell responses to multiple emerging viral pathogens and identifying best in class antibodies for therapeutic development.